DK0983995T3 - Dimethyl-(3-aryl-but-3-enyl)-aminforbindelser som farmaceutiske, aktive stoffer - Google Patents

Dimethyl-(3-aryl-but-3-enyl)-aminforbindelser som farmaceutiske, aktive stoffer

Info

Publication number
DK0983995T3
DK0983995T3 DK99119109T DK99119109T DK0983995T3 DK 0983995 T3 DK0983995 T3 DK 0983995T3 DK 99119109 T DK99119109 T DK 99119109T DK 99119109 T DK99119109 T DK 99119109T DK 0983995 T3 DK0983995 T3 DK 0983995T3
Authority
DK
Denmark
Prior art keywords
enyl
aryl
dimethyl
active substances
amine compounds
Prior art date
Application number
DK99119109T
Other languages
Danish (da)
English (en)
Inventor
Helmut Heinrich Buschmann
Babette-Yvonne Koegel
Wolfgang Werner A Strassburger
Elmar Josef Friderichs
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK0983995T3 publication Critical patent/DK0983995T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/28—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by unsaturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK99119109T 1996-03-13 1997-02-22 Dimethyl-(3-aryl-but-3-enyl)-aminforbindelser som farmaceutiske, aktive stoffer DK0983995T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19609847A DE19609847A1 (de) 1996-03-13 1996-03-13 Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
EP97102923A EP0799819B1 (de) 1996-03-13 1997-02-22 1-Dimethylaminomethyl-2-phenyl-cycloalk-2-enverbindungen mit analgetischer Wirkung

Publications (1)

Publication Number Publication Date
DK0983995T3 true DK0983995T3 (da) 2004-05-24

Family

ID=7788151

Family Applications (3)

Application Number Title Priority Date Filing Date
DK99119109T DK0983995T3 (da) 1996-03-13 1997-02-22 Dimethyl-(3-aryl-but-3-enyl)-aminforbindelser som farmaceutiske, aktive stoffer
DK97102923T DK0799819T3 (da) 1996-03-13 1997-02-22 1-Dimethylaminomethyl-2-phenylcycloalk-2-enforbindelser med analgesisk virkning
DK00116745T DK1069106T3 (da) 1996-03-13 1997-02-22 Dimethyl-(3-aryl-but-3-enyl)-aminforbindelser med analgetisk virkning

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK97102923T DK0799819T3 (da) 1996-03-13 1997-02-22 1-Dimethylaminomethyl-2-phenylcycloalk-2-enforbindelser med analgesisk virkning
DK00116745T DK1069106T3 (da) 1996-03-13 1997-02-22 Dimethyl-(3-aryl-but-3-enyl)-aminforbindelser med analgetisk virkning

Country Status (28)

Country Link
US (1) US5811582A (ru)
EP (4) EP0983994A3 (ru)
JP (2) JP4205182B2 (ru)
KR (2) KR100538662B1 (ru)
CN (1) CN1157366C (ru)
AR (1) AR008991A1 (ru)
AT (3) ATE258544T1 (ru)
AU (1) AU725430B2 (ru)
BR (1) BR9700369B1 (ru)
CA (1) CA2199679C (ru)
CO (1) CO4520279A1 (ru)
CZ (1) CZ293971B6 (ru)
DE (4) DE19609847A1 (ru)
DK (3) DK0983995T3 (ru)
ES (3) ES2183030T3 (ru)
HK (2) HK1026197A1 (ru)
HU (1) HU224819B1 (ru)
IL (1) IL120430A (ru)
NO (1) NO308294B1 (ru)
NZ (1) NZ314384A (ru)
PE (1) PE55798A1 (ru)
PL (1) PL186050B1 (ru)
PT (3) PT1069106E (ru)
RU (1) RU2167146C2 (ru)
SI (3) SI0983995T1 (ru)
SK (1) SK284328B6 (ru)
UA (1) UA55373C2 (ru)
ZA (1) ZA972147B (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
DE19732928C2 (de) * 1997-07-31 2000-05-18 Gruenenthal Gmbh Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel
DE19830105C1 (de) * 1998-07-06 2000-02-17 Gruenenthal Gmbh Acridinderivate
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
DE10000311A1 (de) * 2000-01-05 2001-07-12 Gruenenthal Gmbh Aminomethyl-Phonyl-Cyclohexanonderivate
DE10025948A1 (de) * 2000-05-26 2001-11-29 Gruenenthal Gmbh Wirkstoffkombination
DE10049483A1 (de) † 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
DE10049481A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte C-Cyclohexylmethylamin-Derivate
DE10059413A1 (de) * 2000-11-30 2002-06-20 Gruenenthal Gmbh Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
US20050176790A1 (en) 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
EP1397126B9 (en) 2001-03-16 2007-02-21 DMI Biosciences, Inc. Use of tramadol for delaying ejaculation
DE10132747A1 (de) * 2001-07-05 2003-01-23 Gruenenthal Gmbh Substituierte 1-Aryl-but-3-enylamin- und 1-Aryl-but-2-enylaminverbindungen
DE10146275A1 (de) 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
DE10224624A1 (de) * 2002-05-30 2003-12-11 Gruenenthal Gmbh Metabolite und Prodrugs von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol
DE10225315A1 (de) * 2002-06-06 2003-12-24 Gruenenthal Gmbh Wirkstoffsalze und Ester von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl- pentan-3-ol und 3-(3-Dimethylamino-1-ethyl-1-hydroxy-2-methyl- propyl)-phenol
DE10261091A1 (de) * 2002-12-20 2004-07-01 Grünenthal GmbH Gesättigte und ungesättigte Heteroarylcycloalkylmethyl-Amine
DE10326097A1 (de) * 2003-06-06 2005-01-05 Grünenthal GmbH Verfahren zur Herstellung von Dimethyl-(3-aryl-butyl)-aminverbindungen
DE10328316A1 (de) * 2003-06-23 2005-01-20 Grünenthal GmbH Verfahren zur Herstellung von Dimethyl-(3-aryl-buthyl)-aminverbindungen als pharmazeutische Wirkstoffe
DE102004034619A1 (de) * 2004-07-16 2006-02-23 Grünenthal GmbH Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer
DE102005033732B4 (de) * 2005-05-27 2014-02-13 Grünenthal GmbH Trennung stereoisomerer N,N-Dialkylamino-2-alkyl-3-hydroxy-3-phenyl-alkane
DE102005052588A1 (de) 2005-11-02 2007-05-10 Grünenthal GmbH Verfahren zur Herstellung substituierter Dimethyl-(3-aryl-butyl)-amin-Verbindungen mittels homogener Katalyse
DE102005061429A1 (de) * 2005-12-22 2007-06-28 Grünenthal GmbH Substituierte Oxazol-Derivate
TWI496762B (zh) * 2006-07-24 2015-08-21 製備（１ｒ，２ｒ）-３-（３-二甲胺基-１-乙基-２-甲基-丙基）-酚之方法
EA015003B1 (ru) * 2006-07-24 2011-04-29 Янссен Фармацевтика Нв Получение (2r,3r)-3-(3-метоксифенил)-n,n,2-триметилпентанамина
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
EP2619174A4 (en) * 2010-09-20 2014-05-14 Ind Swift Lab Ltd PROCESS FOR THE PREPARATION OF L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVES
EP2674414A1 (en) 2012-06-15 2013-12-18 Siegfried AG Method for the preparation of 1-aryl-1-alkyl-3-dialkylaminopropane compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518663A1 (de) * 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
US3978129A (en) * 1972-01-28 1976-08-31 A. H. Robins Company, Incorporated Alkenyl- and alkanylamines
DE2409990C2 (de) * 1974-02-27 1982-11-25 Siemens AG, 1000 Berlin und 8000 München Meßwandler für Hochspannungsschaltanlagen mit Metallkapselung
GB1502635A (en) * 1974-02-27 1978-03-01 Schering Ag Process for splitting steroid ethers
JPS598259B2 (ja) * 1976-01-01 1984-02-23 武田薬品工業株式会社 新規シクロヘキセン誘導体
US4173649A (en) * 1978-02-27 1979-11-06 E. R. Squibb & Sons, Inc. 5-Phenyl-2,4-pentadien-1-amines and method for inhibiting prostaglandin dehydrogenase
FR2559765B1 (fr) * 1984-02-16 1986-06-13 Rhone Poulenc Sante Nouveaux derives de la phenyl-3 propene-2 amine, leur preparation et les medicaments qui les contiennent
IT1213219B (it) * 1984-09-28 1989-12-14 Consiglio Nazionale Ricerche Derivati amminoalchilnaftalenici ad attivita' farmacologica.
US5430044A (en) * 1987-02-06 1995-07-04 Fisons Corporation Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
SE9202218D0 (sv) * 1992-07-22 1992-07-22 Kabi Pharmacia Ab Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung

Also Published As

Publication number Publication date
ZA972147B (en) 1997-09-17
AR008991A1 (es) 2000-03-08
PT799819E (pt) 2003-01-31
ES2213526T3 (es) 2004-09-01
US5811582A (en) 1998-09-22
CN1163884A (zh) 1997-11-05
DK0799819T3 (da) 2002-12-02
EP0983994A3 (de) 2001-01-10
KR100538662B1 (ko) 2006-03-28
SK32197A3 (en) 1997-12-10
CZ293971B6 (cs) 2004-09-15
EP0799819B1 (de) 2002-09-11
ES2218924T3 (es) 2004-11-16
EP1069106B1 (de) 2004-01-28
KR970065504A (ko) 1997-10-13
PL318922A1 (en) 1997-09-15
CN1157366C (zh) 2004-07-14
NO971137D0 (no) 1997-03-12
PL186050B1 (pl) 2003-09-30
HUP9700574A3 (en) 2000-01-28
EP0799819A1 (de) 1997-10-08
DK1069106T3 (da) 2004-04-19
DE59711267D1 (de) 2004-03-04
ATE258544T1 (de) 2004-02-15
JPH107624A (ja) 1998-01-13
EP1069106A2 (de) 2001-01-17
HUP9700574A2 (hu) 1998-10-28
NO971137L (no) 1997-09-15
ATE223888T1 (de) 2002-09-15
BR9700369B1 (pt) 2009-01-13
MX9701865A (es) 1997-09-30
CO4520279A1 (es) 1997-10-15
KR100602810B1 (ko) 2006-07-20
NO308294B1 (no) 2000-08-28
EP0983995A3 (de) 2001-01-10
NZ314384A (en) 1999-06-29
DE59711477D1 (de) 2004-05-06
HK1026197A1 (en) 2000-12-08
CZ75997A3 (cs) 1998-04-15
SI0799819T1 (en) 2003-02-28
ATE263140T1 (de) 2004-04-15
EP0983995A2 (de) 2000-03-08
PT983995E (pt) 2004-08-31
PE55798A1 (es) 1998-10-24
HK1031864A1 (en) 2001-06-29
AU1625197A (en) 1997-09-18
DE59708160D1 (de) 2002-10-17
BR9700369A (pt) 1998-10-27
PT1069106E (pt) 2004-06-30
JP4205182B2 (ja) 2009-01-07
JP2008273937A (ja) 2008-11-13
SI1069106T1 (en) 2004-04-30
AU725430B2 (en) 2000-10-12
HU9700574D0 (en) 1997-04-28
HU224819B1 (en) 2006-02-28
UA55373C2 (ru) 2003-04-15
SI0983995T1 (en) 2004-10-31
EP0983994A2 (de) 2000-03-08
RU2167146C2 (ru) 2001-05-20
SK284328B6 (sk) 2005-01-03
JP4846750B2 (ja) 2011-12-28
IL120430A0 (en) 1997-07-13
DE19609847A1 (de) 1997-09-18
ES2183030T3 (es) 2003-03-16
IL120430A (en) 2001-01-28
CA2199679A1 (en) 1997-09-13
EP0983995B1 (de) 2004-03-31
EP1069106A3 (de) 2001-01-24
CA2199679C (en) 2005-07-05

Similar Documents

Publication Publication Date Title
DK0983995T3 (da) Dimethyl-(3-aryl-but-3-enyl)-aminforbindelser som farmaceutiske, aktive stoffer
DK0753506T3 (da) 6-Dimethylaminomethyl-1-phenyl-cyclohexanforbindelser som farmaceutisk aktive stoffer
DK0780369T3 (da) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
DK0942901T3 (da) Cycliske iminer som pesticider
BR9805993B1 (pt) composição farmacêutica de aerossol.
NO986023L (no) Vannbasert, farmas°ytisk preparat
TR199901077A3 (tr) Ispençiyari formülasyonlar.
FI931278A (fi) Polymerer, som innehaoller sulfogrupper
TR199800631A3 (tr) Ecza formülasyonu.
FI915697A (fi) N,o-sulfaterade heparosaner, foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaollande dem.
NO20013242L (no) Benzopyraner og benzoksepiner, farmasöytiske preparater som omfatter dem, og fremgangsmåte for fremstilling av dem
KR100547921B1 (ko) 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물
DK0732146T3 (da) Katalysatorer, som opnås ved tablettering
DK1197216T3 (da) Farmaceutisk ellere kosmetisk sammensætning, der indholder polymere glucanetherderivater
DE69821977D1 (de) Flüssige, insektizide aufgiessformulierung
FI915492A0 (fi) 9a-hydroxi-19,11b-oeverbryggade steroider, deras framstaellning och farmaceutiska preparat som innehaoller dem.
NO960272D0 (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
FI941307A0 (fi) Tjulvalarm, som aktiveras av foeremaolets, som skall skyddas, roerelse
FI924171A (fi) Heteropolycykliska biocida foereningar, deras syntes och mellanprodukter, sammansaettningar som innehaoller dem och deras anvaendning i medicin
NO20000434D0 (no) Lyksofuranosyl benzimidazoler som antivirale midler
MA26604A1 (fr) Compositions pharmaceutiques.
TR199700771A3 (tr) Sinerjistik aktif madde kombinasyonlari.
TR199700863A3 (tr) Paklitaksel hazirlama prosesi.
TR199601018A1 (tr) Farmasötik bilesikler.